Found 6 matching trials
Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma
PHASE1In the Netherlands a 2 center investigator-driven phase I/II clinical trial...
Location
ERasmus Medical Center
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
UT MD Anderson Cancer Center
Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients
PHASE1The primary purpose of this study is to determine the maximally tolerated d...
Location
UAB Highlands, 1201 11th Ave S, 4th Floor, Gynecologic Oncology
DNX-2401 With Interferon Gamma (IFN-ฮณ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
PHASE1Glioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive ...
Location
Moffitt Cancer Center
Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
PHASE1Phase I trial, unicentric, uncontrolled. Intratumoral injection or intramur...
Location
Clinica Universidad de Navarra
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
PHASE2Glioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive ...
Location
University of Arkansas for Medical Sciences (UAMS)